Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Rapid Emergence of Oseltamivir Resistance
  • Published Date:
    Apr 2010
  • Source:
    Emerg Infect Dis. 16(4):723-725.
Filetype[PDF-142.76 KB]


No Related Documents.
You May Also Like:
  1. H275Y Mutant Pandemic (H1N1) 2009 Virus in Immunocompromised Patients
    Personal Author:
    Renaud, Christian; Boudreault, Alexandre A.; Kuypers, Jane; Lofy, Kathryn H.; Corey, Lawrence; Boeckh, Michael J.; Englund, Janet A.;
    Published Date:
    Apr 2011
    Source:
    Emerg Infect Dis. 17(4):653-660.
    Description:
    Most oseltamivir-resistant pandemic (H1N1) 2009 viruses have been isolated from immunocompromised patients. To describe the clinical features, treatment, outcomes, and virologic data associated with infection from pandemic (H1N1) 2009 virus with H275...
    File Type:
    Filetype[PDF - 420.34 KB]
  2. Emergence of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus within 48 Hours
    Personal Author:
    Inoue, Masafumi; Barkham, Timothy; Leo, Yee-Sin; Chan, Kwai-Peng; Chow, Angela; Wong, Christopher W.; Lee, Raphael Tze-Chuen; Maurer-Stroh, Sebastian; Lin, Raymond; Lin, Cui;
    Published Date:
    Oct 2010
    Source:
    Emerg Infect Dis. 16(10):1633-1636.
    Description:
    An oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus evolved and emerged from zero to 52% of detectable virus within 48 hours of a patient's exposure to oseltamivir. Phylogenetic analysis and data gathered by pyrosequencing and cloning dir...
    File Type:
    Filetype[PDF - 384.84 KB]
  3. Antiviral Drugs for Treatment of Patients Infected with Pandemic (H1N1) 2009 Virus
    Personal Author:
    Hartley, David M.; Nelson, Noele P.; Perencevich, Eli N.;
    Published Date:
    Nov 2009
    Source:
    Emerg Infect Dis. 15(11):1851-1852.
    File Type:
    Filetype[PDF - 143.42 KB]
  4. Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein
    Personal Author:
    Triana-Baltzer, Gallen B.; Gubareva, Larisa V.; Nicholls, John M.; Pearce, Melissa B.; Mishin, Vasiliy P.; Belser, Jessica A.; Chen, Li-Mei; Chan, Renee W. Y.; Chan, Michael C. W.; Hedlund, Maria; Larson, Jeffrey L.; Moss, Ronald B.; Katz, Jacqueline M.; Tumpey, Terrence M.; Fang, Fang;
    Published Date:
    November 06 2009
    Source:
    PLoS One. 2009; 4(11)
    Description:
    BackgroundThe recent emergence of a novel pandemic influenza A(H1N1) strain in humans exemplifies the rapid and unpredictable nature of influenza virus evolution and the need for effective therapeutics and vaccines to control such outbreaks. However,...
    File Type:
    Filetype[PDF - 267.32 KB]
  5. Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART
    Personal Author:
    Gubareva, Larisa V; Fallows, Eric; Mishin, Vasiliy P; Hodges, Erin; Brooks, Abdullah; Barnes, John; Fry, Alicia M; Kramp, William; Shively, Roxanne; Wentworth, David E; Weidemaier, Kristin; Jacobson, Ross;
    Published Date:
    May 04 2017
    Source:
    Euro Surveill. 2017; 22(18)
    Description:
    A new rapid assay for detecting oseltamivir resistance in influenza virus, iART, was used to test 149 clinical specimens. Results were obtained for 132, with iART indicating 41 as 'resistant'. For these, sequence analysis found known and suspected ma...
    File Type:
    Filetype[PDF - 427.60 KB]